Form 8-K - Current report:
SEC Accession No. 0000929638-25-002133
Filing Date
2025-06-04
Accepted
2025-06-04 08:35:37
Documents
15
Period of Report
2025-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8k.htm   iXBRL 8-K 27037
2 exhibit99-1.htm EX-99.1 9108
7 image00001.jpg GRAPHIC 3297
  Complete submission text file 0000929638-25-002133.txt   214748

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA engn-20250603.xsd EX-101.SCH 4383
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20250603_def.xml EX-101.DEF 17911
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20250603_lab.xml EX-101.LAB 26902
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20250603_pre.xml EX-101.PRE 20153
18 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 6163
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 251022004
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)